Drug Channels Archive


Individual mailing archives are available to subscribers only.

Recent
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010

Click a link below to view the mailing archive as if it had been sent to you.

2024-04-22 08:01Visit Drug Channels in Booth #1801 at #Asembia24 for a Special “Ask Me Anything With Adam” (#AMAWA)
2024-04-19 07:47Drug Channels - How GoodRx is Evolving Its Reimbursement Approaches to Help Pharmacies and Consumers
2024-04-16 07:47Drug Channels - The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents
2024-04-12 08:26Drug Channels - How Patient Engagement Can Reduce Brand Launch Risks
2024-04-09 07:47Drug Channels - The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What's Ahead
2024-04-08 07:47Drug Channels - SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
2024-04-05 07:47Drug Channels - Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)
2024-04-04 07:47Drug Channels - Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)
2024-04-03 07:47Drug Channels - The Big Three PBMs' 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health's Weird Strategy, and the Insulin Shakeup (rerun)
2024-04-02 07:47Drug Channels - What CVS Pharmacy's New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)
2024-04-01 07:47Drug Channels - Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s (rerun)

Please enter all required fields Click to hide
Correct invalid entries Click to hide
 

Subscribe >>